What are the risks associated with hormone therapy in transgender patients?

Hannah Wenger
, Mari Egan

Department of Medicine

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	3
Number of pages	1
Journal	Evidence-Based Practice
Volume	20
Issue number	5
State	Published - May 2017

All Science Journal Classification (ASJC) codes

Fundamentals and skills

Other files and links

Cite this

@article{63e001cf7c614b83ad11c0c9b081ac7a,

title = "What are the risks associated with hormone therapy in transgender patients?",

author = "Hannah Wenger and Mari Egan",

year = "2017",

month = may,

language = "English (US)",

volume = "20",

pages = "3",

journal = "Evidence-Based Practice",

issn = "1095-4120",

publisher = "Lippincott Williams and Wilkins",

number = "5",

}

TY - JOUR

T1 - What are the risks associated with hormone therapy in transgender patients?

AU - Wenger, Hannah

AU - Egan, Mari

PY - 2017/5

Y1 - 2017/5

UR - https://www.scopus.com/pages/publications/85050774852

UR - https://www.scopus.com/pages/publications/85050774852#tab=citedBy

M3 - Comment/debate

AN - SCOPUS:85050774852

SN - 1095-4120

VL - 20

SP - 3

JO - Evidence-Based Practice

JF - Evidence-Based Practice

IS - 5

ER -